Edgewise Therapeutics, Inc. (EWTX) — Stock Score Summary

Edgewise Therapeutics, Inc. (EWTX) has a MoatMap StockRank of 56/100 based on Quality (41/100), Value (36/100), and Momentum (65/100) factor scores. The current signal is HOLD. Edgewise Therapeutics is a clinical-stage biotech that does not possess manufacturing assets, making it a potential casualty of rising CDMO pricing power.

Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative small molecule therapies for serious rare muscle disorders. The company's competitive moat lies in its novel scientific approach to muscle stabilization and protection, targeting conditions like Duchenne and Becker muscular dystrophy. Edgewise aims to provide orally bioavailable treatments that address significant unmet medical needs, potentially altering the course of these debilitating diseases.

Key Financial Metrics

Price$34.06
Market Cap$3.6B
P/E (Forward)-17.02
Price/Book8.11
Return on Equity-38.1%
Return on Invested Capital-36.4%
Debt/Equity0.77
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-91M

Edgewise Therapeutics, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Edgewise Therapeutics, Inc.’s (EWTX) StockRank?
MoatMap’s StockRank for Edgewise Therapeutics, Inc. (EWTX) is 56/100, with a Hold signal. It is a composite of Quality (41), Value (36), and Momentum (65) factor ranks across MoatMap’s 19,000+ stock universe.
Does Edgewise Therapeutics, Inc. have an economic moat?
Edgewise Therapeutics, Inc. (EWTX) has a Quality factor score of 41/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Edgewise Therapeutics, Inc. a buy, hold, or sell?
MoatMap’s current signal for Edgewise Therapeutics, Inc. (EWTX) is Hold, based on a StockRank of 56/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Edgewise Therapeutics, Inc. in?
Edgewise Therapeutics, Inc. (EWTX) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksEWTX deep dive reportAI ChampionsHow we score stocksSense-check another stock